Benefit finding and its influencing factors in caregivers of hematological tumor patients
HU Miaoye1, 2,ZHENG Xiaofen3, WU Yamei4, ZHANG Chunmei5, 6.
1.The Second School of Medicine, Wenzhou Medical University, Wenzhou 325035, China; 2.Department of Hand Surgery, the Second Affiliated Hospital & Yuying
Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China; 3.Department of Pediatric Nephrology, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University,Wenzhou 325027, China; 4.Department of Hand Surgery/Wound Repair, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China; 5.Department of Party Committee and General Office of Administration, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China; 6.School of Nursing, Wenzhou Medical University, Wenzhou 325035, China
HU Miaoye,ZHENG Xiaofen,WU Yamei, et al. Benefit finding and its influencing factors in caregivers of hematological tumor patients[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2022, 52(11): 889-893.
Abstract：Objective: To explore the current status of benefit finding and its influencing factors among caregivers of patients with hematologic malignancies. Methods: A total of 100 caregivers of patients suffering from hematologic malignancies were selected as the research subjects using the convenience sampling method.A general information questionnaire, benefit finding scale, and perceived social support scale were performed to analyze the benefit finding and its influencing factors. Results: The total score of benefit finding for caregivers of patients with hematologic malignancies was (71.80±16.22), and the disease benefit of caregivers was positively correlated with social support and three dimensions (P<0.001). The results of multiple linear regression analysis showed that physical and mental status and family support were the main influencing factors of disease benefit of caregivers of hematologic malignancies patients (P<0.05), which explained 61.8% of the total variation of
disease benefit of caregivers of hematologic malignancies patients. Conclusion: The benefit finding in caregivers of patients with hematologic malignancies is at a moderate level, and enhancing the social support of caregivers could improve their benefit finding.
